Latest News and Press Releases

LAWRENCE, Mass., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Boston Therapeutics, Inc.  (OTCQB:BTHE) begun the roll-out of its new Multimedia Internet Platform. The redesigned website offers global insight...

LAWRENCE, Mass., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Following the extension of the licensing and distribution agreement with Asian based partner, Advance Pharmaceutical Company Limited (APC), a...

LAWRENCE, Mass., Dec. 06, 2017 (GLOBE NEWSWIRE) -- Boston Therapeutics, Inc is pleased to announce that effective sugar reduction with the investigative BTI320 formulation requires only one tablet....

LAWRENCE, Mass., Nov. 17, 2017 (GLOBE NEWSWIRE) -- On November 16, 2017, Carl W. Rausch, CEO of Boston Therapeutics, Inc., headquartered in Lawrence MA, (OTCQB:BTHE) (“BTI” or the “Company”),...

LAWRENCE, Mass., June 19, 2017 (GLOBE NEWSWIRE) -- Mr. Carl Rausch, CEO of Boston Therapeutics, Inc. (OTCQB:BTHE) and its Asian partner Advance Pharmaceutical Company Limited, Hong Kong had data...

LAWRENCE, MA--(Marketwired - Apr 26, 2017) - Boston Therapeutics, Inc. (OTCQB: BTHE) and its Asian partner Advance Pharmaceutical Company Limited, Hong Kong, announced today the fully financed new...

LAWRENCE, MA--(Marketwired - Feb 7, 2017) -  On February 1, 2017 Boston Therapeutics, Inc., headquartered in Lawrence MA, (OTCQB: BTHE) disclosed its restructured operations activity in a two...

LAWRENCE, MA--(Marketwired - Oct 13, 2016) -  Boston Therapeutics, Inc. (OTCQB: BTHE) - Today Boston Therapeutics and Advance Pharmaceutical Co., Ltd., which holds a license for the...

LAWRENCE, MA--(Marketwired - Oct 6, 2016) - Boston Therapeutics, Inc. (OTCQB: BTHE) and its Asian partner Advance Pharmaceutical Company Limited, Hong Kong presented today the positive topline data...

LAWRENCE, MA--(Marketwired - Oct 3, 2016) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or the "Company") announced that it closed a private placement yielding gross proceeds to...